MannKind Corporation · Valencia, CA United States (NASDAQ: MNKD)
| 28903 N. Ave. Paine | Phone: 661-775-5300 |
| Valencia, CA | Fax: 661-775-2080 |
| 91355 | |
| United States | 
Map This Company |
MannKind Corporation Rankings
More Companies in These Related Industries: Pharmaceutical Preparation MfgCompany Description
With a name like MannKind, what can you do but attempt to improve the well-being of mankind? The biopharmaceutical company focuses on developing and commercializing therapeutic products to treat diabetes and cancer. Its lead product candidate, AFREZZA, uses its Technosphere inhalation system technology to treat type 2 diabetes. The system consists of a special inhaler that releases deep into the lungs a formula of dry powder insulin that could raise insulin levels more quickly and with less discomfort than other methods. The company is also developing therapeutic cancer vaccines that could be injected directly into a patient's lymph nodes. Founder and CEO Alfred Mann owns nearly half of the company.
MannKind Corporation Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - NASDAQ: MNKD Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2010 Employees | 436 |
Executives
30 executives listed for MannKind Corporation's Valencia, CA location.
| Chairman and CEO | Alfred Mann | |
|---|---|---|
| President, COO, and Director | Hakan Edstrom | |
| Corporate VP and CFO | Matthew Pfeffer |